EClinical Solutions Market Size Surpass US$ 27.39 Bn By 2032

The eClinical solutions market size was valued at USD 8.25 billion in 2022 and is expected to reach USD 10.06 billion by 2032, poised to grow at a CAGR of 12.9% from 2023 to 2032.

Table of Contents

Key Takeaways:

North America led the eClinical solutions market with the largest market share of 52% in 2022.
The CTMS segment dominated the eClinical solutions market and accounted for the largest revenue share of over 22% in 2022.
By Delivery Mode, the web-hosted segment dominated the market with the largest revenue share of over 75% in 2022.
By Development Phase, the phase III segment dominated the eClinical solutions market and accounted for the largest revenue share of over 54% in 2022.
The CROs segment dominated the market for eClinical solutions and held the largest revenue share of over 37.06% in 2022.

Growth Factors

Increase in the number of customers adopting eClinical solutions, rising Research and Development (R&D), and rise in government grants to authorize the clinical trials. These solutions are also used in clinical studies where electronic applications enabled with web tools are used to capture the real-time data from clinical trials that provide superior execution and escalate the eClinical solutions market growth.

Rising demand for clinical trials by biopharma and pharma companies boosts the industry demand. They offer services for large consumer base at low operating costs that again propel the eClinical solutions market growth. eClinical solutions also helps in organizing, tracking, and executing data from numerous geographical locations and also triggers the process of clinical development.

Factors such as real-time notifications, real-time reporting, real-time tracking, and configurable report building expected to augment the industry growth in the near future. In addition, eClinical solutions make electronic data capture, clinical data management, statistical programming, data conversion & standardization, and data reporting enormously easy that further drives the eClinical solutions market growth. These solutions also use products, technology, and services to offer clinical trials that reduce human errors and effectively manage large amount of data in real-time. Technological advancements in the eClinical solutions, globalization of clinical trials, enhancement in efficiency provided by eClinical solutions, and reduced costs are some of the main drivers of the eClinical solutions market.

Get a Sample: https://www.precedenceresearch.com/sample/1092

Report Highlights

In 2019, North America captured the highest market value share owing to rising prevalence of lifestyle with several diseases such as cardiac disorder and diabetes
The Asia Pacific exhibits lucrative growth over the analysis period due to rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and infectious diseases
Electronic Clinical Outcome Assessment (eCOA) estimated to be the fastest growing product segment over the analysis period due to rising importance of high-quality clinical data
By development phase, phase III segment lead the global market throughout the forecast period due to rising need for clinical data management software
Phase I likely to execute promising growth during the analysis period owing to increased importance of these systems to analyze future outcomes
Based on delivery mode, web-hosted solutions accounted maximum value share in 2019 due to its benefits that are usability, easy accessibility, and lower investments required
Cloud-based solutions predicted to exhibit strong growth during the analysis period due to integrated features such as high accessibility, flexibility, and easy data backup
CROs dominated the global market and expected to witness notable growth in the coming years owing to the rising concern of pharmaceutical companies to reduce their overall expenditure
Pharmaceutical and biotechnology companies expected to witness prominent growth over the forecast period.

Regional Snapshots

In 2019, North America held significant value share in the global eClinical solutions market owing to increase in the number of clinical trials in the region. Further, rising government grants for clinical trials, huge funding in R&D activities, technological advancements, along with significant rise in the lifestyle associated diseases are the key factors that propel the industry growth.

However, the Asia Pacific encountered an escalating CAGR over the forecast timespan due to the rising investment in R&D. The developing economies in the region such as China, India, and Korea have been pictured as the major destinations for outsourcing the clinical trials because of huge population-base along with low-cost services. Furthermore, lesser stringent laws compared to developed countries, increasing number of patients, and fast patient admission for clinical trials expected to augment the market growth in the region.

Key Players & Strategies

The global eClinical solutions market seeks high competition among the industry participants. These market players are significantly involved in different inorganic growth strategies such as mergers & acquisitions, new product development, and collaborations that help them to maintain their position in the market. For instance, in November 2019, eClinical Works signed a collaboration deal with Trusted Health Plan; GuideWell; and Humana Inc. aiming to offer bidirectional healthcare interoperability solutions to providers, patients, and payers. Similarly, in September 2018, Bracket and CRF Health signed a joint venture agreement under which the newly formed company was renamed as CRF Bracket. The newly formed company offers different services and technologies for clinical research that are used in drug development companies.